Company News for Jan 11, 2021

Zacks Equity Research Published on January 11, 2021

Shares of Chimerix, Inc. (CMRX - Free Report) jumped 69.1% after the company announced that it has acquired Oncoceutics, a clinical-stage biotechnology company developing imipridones for $78 million in cash and stock.
Globalstar, Inc.’s (GSAT - Free Report) shares rose 41.6% after business partner Nokia has entered into an agreement with Tideworks Technology, to deploy Globalstar’s Band 53 spectrum at the Port of Seattle, Terminal 5.
Shares of Merus N.V. (MRUS - Free Report) surged 28.3% after the company announced that FDA granted Fast Track Designation to Zenocutuzumab for the treatment of patients with neuregulin 1 fusion cancers.
F5 Networks, Inc.’s (FFIV - Free Report) shares jumped 17.7% after the company announced plans to acquire Volterra for approximately $500 million.

Zacks Names "Single Best Pick to Double"

From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.

It’s a little-known chemical company that’s up 65% over last year, yet still dirt cheap. With unrelenting demand, soaring 2022 earnings estimates, and $1.5 billion for repurchasing shares, retail investors could jump in at any time.

This company could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in little more than 9 months and NVIDIA which boomed +175.9% in one year.